Tina Vilsbøll

Tina Vilsbøll

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology


  1. Published

    No changes in levels of bone formation and resorption markers following a broad-spectrum antibiotic course

    Mikkelsen, K. H., Vilsbøll, Tina, Holst, Jens Juul, Hartmann, Bolette, Knop, Filip Krag & Frost, M., 2018, In: BMC Endocrine Disorders. 18, 6 p., 60.

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published
  3. Published

    Neutrophil to lymphocyte ratio predicts cardiovascular events in people with type 2 diabetes: Post hoc analysis of the SUSTAIN 6 and PIONEER 6 cardiovascular outcomes trials

    Verma, S., Husain, M., Madsen, C. M., Leiter, L. A., Kuhlman, A. B., Vilsbøll, Tina, Rasmussen, S. & Libby, P., 2023, In: Diabetes, Obesity and Metabolism. 25, 8, p. 2398-2401 4 p.

    Research output: Contribution to journalLetterResearchpeer-review

  4. Published

    Neurotensin secretion after Roux-en-Y gastric bypass, sleeve gastrectomy, and truncal vagotomy with pyloroplasty

    Svane, M. S., Øhrstrøm, C. C., Plamboeck, A., Jørgensen, Nils Bruun, Bojsen-Møller, K. N., Dirksen, C., Martinussen, C., Vilsbøll, Tina, Hartmann, Bolette, Deacon, Carolyn F., Kristiansen, V. B., Knop, Filip Krag, Svendsen, Lars Bo, Madsbad, Sten, Holst, Jens Juul & Veedfald, Simon, 2022, In: Neurogastroenterology and Motility. 34, 1, e14210.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Neuroprotective Mechanisms of Glucagon-like Peptide-1-based Therapies in Ischaemic Stroke: A Systematic Review based on Pre-Clinical Studies

    Marlet, I. R., Ölmestig, J. N. E., Vilsbøll, Tina, Rungby, Jørgen & Kruuse, Christina Rostrup, Jun 2018, In: Basic & Clinical Pharmacology & Toxicology. 122, 6, p. 559-569

    Research output: Contribution to journalReviewResearchpeer-review

  6. Published

    Near-normalization of glycaemic control with glucagon-like peptide-1 receptor agonist treatment combined with exercise in patients with type 2 diabetes

    Mensberg, P., Nyby, S., Jørgensen, P. G., Storgaard, H., Jensen, M. T., Sivertsen, J., Holst, Jens Juul, Kiens, Bente, Richter, Erik A., Knop, Filip Krag & Vilsbøll, Tina, 2017, In: Diabetes, Obesity and Metabolism. 19, 2, p. 172-180 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Mono- and co-activation of the GIP and GLP-1 receptors inhibits bone resorption

    Bergmann, N. C., Lund, A., Heimburger, S. M., Gasbjerg, Lærke Smidt, Jørgensen, Niklas Rye, Jessen, L., Hartmann, Bolette, Holst, Jens Juul, Christensen, Mikkel Bring, Vilsbøll, Tina & Knop, Filip Krag, 2018, In: Diabetologia. 61, S.1, p. S348-S348 717.

    Research output: Contribution to journalConference abstract in journalResearch

  8. Published

    Model-Based Prediction of Plasma Concentration and Enterohepatic Circulation of Total Bile Acids in Humans

    Guiastrennec, B., Sonne, David Peick, Bergstrand, M., Vilsbøll, Tina, Knop, Filip Krag & Karlsson, M. O., 2018, In: C P T: Pharmacometrics & Systems Pharmacology. 7, 9, p. 603-612

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Metformin-induced glucagon-like peptide-1 secretion contributes to the actions of metformin in type 2 diabetes

    Bahne, E., Sun, E. W. L., Young, R. L., Hansen, M., Sonne, D. P., Hansen, J. S., Rohde, U., Liou, A. P., Jackson, M. L., de Fontgalland, D., Rabbitt, P., Hollington, P., Sposato, L., Due, S., Wattchow, D. A., Rehfeld, Jens Frederik, Holst, Jens Juul, Keating, D. J., Vilsbøll, Tina & Knop, Filip Krag, 2018, In: JCI Insight. 3, 23, p. 1-16 e93936.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Metformin-associated risk of acute dialysis in patients with type 2 diabetes: A nationwide cohort study

    Carlson, N., Hommel, K., Olesen, J. B., Gerds, Thomas Alexander, Soja, A. M. B., Vilsbøll, Tina, Kamper, A., Torp-Pedersen, C. & Gislason, Gunnar Hilmar, Dec 2016, In: Diabetes, Obesity and Metabolism. 18, 12, p. 1283-1287 5 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    Metformin potentiates bile acid-induced GLP-1 secretion in patients with type 2 diabetes

    Bronden, A., Alber, A., Rohde, U., Rehfeld, Jens Frederik, Holst, Jens Juul, Vilsbøll, Tina & Knop, Filip Krag, 2017, In: Diabetologia. 60, p. 113-113 242.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  12. Published

    Metformin er en mulig glukagonlignende peptid-1-stimulator

    Bahne, E., Brønden, A., Vilsbøll, Tina & Knop, Filip Krag, 2018, In: Ugeskrift for Laeger. 180, 12, 4 p., V07170516.

    Research output: Contribution to journalJournal articleResearchpeer-review

  13. Published

    Metabolic effects of one-week binge drinking and fast food intake during Roskilde Festival in young healthy male adults

    Demant, Mia Grønlund, Suppli, M. P., Foghsgaard, S., Gether, L., Grøndahl, M. F. G., Dalsgaard, N. B., Bergmann, S. S., Lanng, A. R., Gasbjerg, Lærke Smidt, Thomasen, M., Bagger, J. I., Strandberg, C., Kønig, M. J., Grønbæk, H., Becker, U., Holst, Jens Juul, Knop, J., Gillum, M. P., Vilsbøll, Tina & Knop, Filip Krag, Apr 2021, In: European Journal of Endocrinology. 185, 1, p. 23-32

    Research output: Contribution to journalJournal articleResearchpeer-review

  14. Published

    Mechanism-Based Modeling of Gastric Emptying Rate and Gallbladder Emptying in Response to Caloric Intake

    Guiastrennec, B., Sonne, D. P., Hansen, M., Bagger, J. I., Lund, A., Rehfeld, Jens Frederik, Alskär, O., Karlsson, M. O., Vilsbøll, Tina, Knop, Filip Krag & Bergstrand, M., Dec 2016, In: C P T: Pharmacometrics & Systems Pharmacology. 5, 12, p. 692-700 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  15. Published

    Mathematical Modelling of Glucose-Dependent Insulinotropic Polypeptide and Glucagon-like Peptide-1 following Ingestion of Glucose

    Røge, R. M., Bagger, J. I., Alskär, O., Kristensen, N. R., Klim, S., Holst, Jens Juul, Ingwersen, S. H., Karlsson, M. O., Knop, Filip Krag, Vilsbøll, Tina & Kjellsson, M. C., Oct 2017, In: Basic & Clinical Pharmacology & Toxicology. 121, 4, p. 290-297 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  16. Published

    Management of people with Type 2 diabetes shared between a specialized outpatient clinic and primary health care is noninferior to management in a specialized outpatient clinic: a randomized, noninferiority trial

    Munch, L., Bennich, B. B., Overgaard, D., Konradsen, H., Middelfart, H., Kaarsberg, N., Knop, Filip Krag, Vilsbøll, Tina & Røder, M. E., 2019, In: Diabetic Medicine. 36, 7, p. 854-861

    Research output: Contribution to journalJournal articleResearchpeer-review

  17. Published

    Management of Patients with Type 2 Diabetes Shared between a Specialized Outpatient Clinic and General Practice Was Noninferior to Mono Management in a Specialized Outpatient Clinic—A Prospective, Randomized, Noninferiority Trial

    Munch, L., Bennich, B. B., Overgaard, D., Konradsen, Hanne, Middelfart, H. V., Kaarsberg, N., Knop, Filip Krag, Vilsbøll, Tina & Røder, M., 2018, In: Diabetes. 67, Supplement 1, 6-OR.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  18. Published

    MR-proANP and incident cardiovascular disease in patients with type 2 diabetes with and without heart failure with preserved ejection fraction

    Jensen, J., Schou, Morten, Kistorp, Caroline Michaela Nervil, Faber, Jens, Hansen, T. W., Jensen, M. T., Andersen, H. U., Rossing, Peter, Vilsbøll, Tina & Jørgensen, P. G., 2020, In: Cardiovascular Diabetology. 19, 1, 180.

    Research output: Contribution to journalJournal articleResearchpeer-review

  19. Published

    Loss of Incretin Effect Is a Specific, Important, and Early Characteristic of Type 2 Diabetes

    Holst, Jens Juul, Knop, Filip Krag, Vilsbøll, Tina, Krarup, T. & Madsbad, Sten, May 2011, In: Diabetes Care. 34, Supplement 2, p. S251-7 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  20. Published

    Long-term follow-up on patient-reported outcomes after supervised exercise training in individuals at risk of complications to type 2 diabetes

    Danielsen, J. H., Nielsen, S. G., Varming, A. R., Vilsbøll, Tina & Mølsted, Stig, 2024, In: Diabetes and Metabolic Syndrome: Clinical Research and Reviews. 18, 2, 7 p., 102953.

    Research output: Contribution to journalJournal articleResearchpeer-review

  21. Published

    Long-acting GLP-1 analogs for the treatment of type 2 diabetes mellitus

    Vilsbøll, Tina & Knop, Filip Krag, 1 Jan 2008, In: BioDrugs. 22, 4, p. 251-7 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  22. Published

    Lixisenatide for type 2 diabetes mellitus

    Christensen, M., Knop, Filip Krag, Vilsbøll, Tina & Holst, Jens Juul, 2011, In: Expert Opinion on Investigational Drugs. 20, 4, p. 549-57 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  23. Published

    Liraglutide: a once-daily GLP-1 analogue for the treatment of type 2 diabetes mellitus

    Vilsbøll, Tina, 1 Feb 2007, In: Expert Opinion on Investigational Drugs. 16, 2, p. 231-7 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  24. Published

    Liraglutide: a new treatment for type 2 diabetes

    Vilsbøll, Tina, 2009, In: Drugs of Today. 45, 2, p. 101-13 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  25. Published

    Liraglutide: a human GLP-1 analog for Type 2 diabetes

    Vilsbøll, Tina, 2009, In: Therapy. 6, 2, p. 199-207 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  26. Published

    Liraglutide, a once-daily human GLP-1 analogue, improves pancreatic B-cell function and arginine-stimulated insulin secretion during hyperglycaemia in patients with Type 2 diabetes mellitus

    Vilsbøll, Tina, Brock, B., Perrild, H., Levin, K., Lervang, H., Kølendorf, K. E., Krarup, T., Schmitz, O., Zdravkovic, M., Le Thi Thanh, X. & Madsbad, Sten, 1 Feb 2008, In: Diabetic Medicine. 25, 2, p. 152-6 5 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  27. Published

    Liraglutide, a long-acting human glucagon-like peptide-1 analog, given as monotherapy significantly improves glycemic control and lowers body weight without risk of hypoglycemia in patients with type 2 diabetes

    Vilsbøll, Tina, Zdravkovic, M., Le-Thi, T., Krarup, T., Schmitz, O., Courrèges, J., Verhoeven, R., Bugánová, I. & Madsbad, Sten, 1 Jun 2007, In: Diabetes Care. 30, 6, p. 1608-10 3 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  28. Published

    Liraglutide treatment for the prevention of glucose tolerance deterioration in women with prior gestational diabetes mellitus: A 52-week randomized controlled clinical trial

    Foghsgaard, S., Vedtofte, L., Andersen, E. S., Bahne, E., Andreasen, C., Sørensen, A. L., Forman, Julie Lyng, Mathiesen, Elisabeth, Svare, J. A., Clausen, Tine Dalsgaard, Damm, Peter, Holst, Jens Juul, Knop, Filip Krag & Vilsbøll, Tina, 2023, In: Diabetes, Obesity and Metabolism. 26, 1, p. 201-214 14 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  29. Published

    Liraglutide for the Treatment of Antipsychotic Drug-Induced Weight Gain: Reply

    Fink-Jensen, Anders, Correll, C. U. & Vilsbøll, Tina, Nov 2017, In: J A M A Psychiatry. 74, 11, p. 1173-1174 2 p.

    Research output: Contribution to journalComment/debateResearch

  30. Published

    Liraglutide does not change bone turnover in clozapine- and olanzapine-treated schizophrenia overweight patients with prediabetes – randomized controlled trial

    Maagensen, H., Larsen, J. R., Jørgensen, Niklas Rye, Fink-Jensen, Anders & Vilsbøll, Tina, 2021, In: Psychiatry Research. 296, 113670.

    Research output: Contribution to journalJournal articleResearchpeer-review

  31. Published

    Liraglutide decreases postprandial fibroblast growth factor 19 and glucagon-like peptide 2, and increases postprandial cholecystokinin in individuals with obesity

    Bronden, A., Nerild, H. H., Nexoe-Larsen, C. C., Hellmann, P. H., Baekdal, M., Gether, I. M., Gillum, M. P., Hartmann, Bolette, Knudsen, L. B., Jacobsen, L. V., Rehfeld, Jens Frederik, Holst, Jens Juul, Vilsbøll, Tina, Sonne, D. P. & Knop, Filip Krag, 2021, In: Diabetologia. 64, SUPPL 1, p. 94-94 177.

    Research output: Contribution to journalConference abstract in journalResearch

  32. Published

    Liraglutide changes postprandial responses of gut hormones involved in the regulation of gallbladder motility

    Nerild, H. H., Brønden, Andreas, Gether, I. M., Hellmann, P. H., Baekdal, M., Gillum, M. P., Svenningsen, J. S., Hartmann, Bolette, Rathor, N., Kudiyanur Muniraju, H. A., Rehfeld, Jens Frederik, Holst, Jens Juul, Vilsbøll, Tina, Sonne, David Peick & Knop, Filip Krag, 2023, In: Diabetes, Obesity and Metabolism. 25, 6, p. 1632-1637

    Research output: Contribution to journalJournal articleResearchpeer-review

  33. Published

    Liraglutide 3.0 mg once daily for the treatment of overweight and obesity in patients hospitalised at a forensic psychiatric department: A 26-week open-label feasibility study

    Sass, M. R., Christensen, A. M. B., Christensen, M. L., Gruber, E., Nerdrum, H., Pedersen, L. M., Resch, M., Jørgensen, T. H., Ekstrøm, Claus Thorn, Nielsen, Jimmi, Vilsbøll, Tina & Fink-Jensen, Anders, 2024, In: Acta Psychiatrica Scandinavica. 150, 1, p. 35-47 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  34. Published

    Leptin Serum Levels are Associated With GLP-1 Receptor Agonist-Mediated Effects on Glucose Metabolism in Clozapine-or Olanzapine-Treated, Prediabetic, Schizophrenia Patients

    Tomasik, J., Rustogi, N., Larsen, J. R., Jakobsen, M. I., Svensson, C. K., Vedtofte, L., Jakobsen, M. S. L., Jespersen, H. R., Koyuncu, K., Schjerning, O., Nielsen, Jimmi, Ekstrøm, Claus Thorn, Correll, C. U., Holst, Jens Juul, Vilsbøll, Tina, Bahn, S. & Fink-Jensen, Anders, 2020, In: Schizophrenia Bulletin Open. 1, 1, 11 p., sgaa044.

    Research output: Contribution to journalJournal articleResearchpeer-review

  35. Published

    Lean Women with Polycystic Ovary Syndrome and Insulin Resistance Have Normal Incretin Effect, which Is Unaffected by Metformin Therapy

    Vedtofte, L., Foghsgaard, S., Zierau, L., Vilsbøll, Tina & Knop, Filip Krag, 2019, In: Diabetes. 68, Supplement 1, 1 p., 1186-P.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  36. Published

    LEAP2 reduces postprandial glucose excursions and ad libitum food intake in healthy men

    Hagemann, C. A., Jensen, M. S., Holm, Stephanie Kjærulff, Gasbjerg, Lærke Smidt, Byberg, Sarah, Skov-Jeppesen, Kirsa, Hartmann, Bolette, Holst, Jens Juul, Dela, Flemming, Vilsbøll, Tina, Christensen, Mikkel Bring, Holst, Birgitte & Knop, Filip Krag, 2022, In: Cell Reports Medicine. 3, 4, 100582.

    Research output: Contribution to journalJournal articleResearchpeer-review

  37. Published

    KATP channel closure ameliorates the impaired insulinotropic effect of glucose-dependent insulinotropic polypeptide (GIP) in patients with type 2 diabetes

    Aaboe, K., Knop, Filip Krag, Vilsbøll, Tina, Vølund, A., Simonsen, U., Deacon, Carolyn F., Madsbad, Sten, Holst, Jens Juul & Krarup, T., 2009, In: Journal of Clinical Endocrinology and Metabolism. 94, 2, p. 603-608

    Research output: Contribution to journalJournal articleResearchpeer-review

  38. Published
  39. Published

    Is the current therapeutic armamentarium in diabetes enough to control the epidemic and its consequences? What are the current shortcomings?

    Giugliano, D., Standl, E., Vilsbøll, Tina, Betteridge, J., Bonadonna, R., Campbell, I. W., Schernthaner, G., Staels, B., Trichopoulou, A. & Farinaro, E., 2009, In: Acta Diabetologica. 46, 3, p. 173-81 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  40. Published

    Is glucagon‐like peptide‐1 fully protected by the dipeptidyl peptidase 4 inhibitor sitagliptin when administered to patients with type 2 diabetes?

    Andersen, E. S., Lund, A., Bagger, J. I., Andreasen, C., Grøndahl, M., Deacon, Carolyn F., Hartmann, Bolette, Holst, Jens Juul, Knop, Filip Krag & Vilsbøll, Tina, Aug 2018, In: Diabetes, Obesity and Metabolism. 20, 8, p. 1937-1943

    Research output: Contribution to journalJournal articleResearchpeer-review

  41. Published

    Is double-blinding achievable in a placebo-controlled trial with the glucagon-like-peptide-1 receptor agonist liraglutide?

    Foghsgaard, S., Vedtofte, L., Bahne, E., Andreasen, C., Christiansen, L. K., Svare, J. A., Clausen, Tine Dalsgaard, Mathiesen, Elisabeth, Damm, Peter, Gluud, Lise Lotte, Knop, Filip Krag & Vilsbøll, Tina, 2017, In: Diabetologia. 60, S1, p. S369-S369

    Research output: Contribution to journalConference abstract in journalResearch

  42. Published

    Involvement of steatosis-induced glucagon resistance in hyperglucagonaemia

    Suppli, M. P., Lund, Asger Bach, Bagger, J. I., Vilsbøll, Tina & Knop, Filip Krag, Jan 2016, In: Medical Hypotheses. 86, p. 100-3 4 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  43. Published

    Involvement of glucagon-like peptide-1 in the glucose-lowering effect of metformin

    Bahne, E., Hansen, M., Brønden, A., Sonne, David Peick, Vilsbøll, Tina & Knop, Filip Krag, Oct 2016, In: Diabetes, Obesity and Metabolism Online. 18, 10, p. 955-61 7 p.

    Research output: Contribution to journalReviewResearchpeer-review

  44. Published

    Investigating Intestinal Glucagon after Roux-en-Y Gastric Bypass Surgery

    Jorsal, T., Wewer Albrechtsen, N. J., Christensen, M. M., Mortensen, B., Wandall, E., Langholz, E., Friis, S., Worm, D., Ørskov, C., Støving, R. K., Andries, A., Juhl, C. B., Sørensen, F., Forman, J. L., Falkenhahn, M., Musholt, P. B., Theis, S., Larsen, P. J., Holst, J. J., Vrang, N. & 3 others, Jelsing, J., Vilsbøll, Tina & Knop, Filip Krag, 2019, In: Journal of Clinical Endocrinology and Metabolism. 104, 12, p. 6403–6416 14 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  45. Published

    Intrauterin insemination med donorsaed. Behandling af ufrivillig barnløshed på grund af mandlig infertilitet

    Vilsbøll, Tina, Helmsøe-Zinck, L. & Andersen, A. N., 22 Aug 1994, In: Ugeskrift for Laeger. 156, 34, p. 4826-9 4 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  46. Published

    Intestinal expression profiles and hepatic expression of LEAP2, ghrelin and their common receptor, GHSR, in humans

    Englund, A., Gilliam-Vigh, H., Suppli, M. P., Gasbjerg, Lærke Smidt, Vilsbøll, Tina & Knop, Filip Krag, 2024, In: Peptides. 177, 7 p., 171227.

    Research output: Contribution to journalJournal articleResearchpeer-review

  47. Published

    Intention and perceptions of healthy eating versus actual intake among patients with type 1 and type 2 diabetes and the general population

    Ewers, B., Sørensen, M. R., Fagt, S., Diaz, L. J. & Vilsbøll, Tina, 2021, In: Patient Preference and Adherence. 15, p. 2027-2037 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  48. Published

    Insulin degludec/liraglutide (IDegLira) maintains glycaemic control and improves clinical outcomes, regardless of pre-trial insulin dose, in people with type 2 diabetes that is uncontrolled on basal insulin

    Meneghini, L., Doshi, A., Gouet, D., Vilsbøll, Tina, Begtrup, K., Őrsy, P., Ranthe, M. F. & Lingvay, I., 2020, In: Diabetic Medicine. 37, 2, p. 267-276 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  49. Published

    Inkretiner

    Vilsbøll, Tina & Holst, Jens Juul, 2011, Diabetes - sygdom, behandling og organisation. Hilsted, J., Borch-Johnsen, K. & Christiansen, J. S. (eds.). 2 ed. København: Munksgaard , p. 67-74 8 p.

    Research output: Chapter in Book/Report/Conference proceedingBook chapterCommunication

  50. Published

    Influence of gastrointestinal factors on glucose metabolism in patients with cirrhosis

    Junker, A. E., Gluud, Lise Lotte, Holst, Jens Juul, Knop, Filip Krag & Vilsbøll, Tina, Oct 2015, In: Journal of Gastroenterology and Hepatology. 30, 10, p. 1522-8 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 33056950